
Medico Remedies vs Nifty 50: Share Price Performance Compared
Medico Remedies share price Rs 22.17 on NSE. Medico Remedies vs Nifty 50 over 1 year: -56.35% vs -9.29%. 52-week high Rs 56.88, low Rs 20.47.
Updated: 7 Oct 2026 • 9:45 am
Posted by:

Quick Answer
Medico Remedies vs Nifty 50 shows Medico Remedies trailing the benchmark on a one-year view, with a return of -56.35% against the Nifty 50's -9.29%. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons. Investors comparing the two should also weigh Medico Remedies's trading liquidity, valuation and sector context rather than relying on returns alone.
Medico Remedies vs Nifty 50 is a comparison that looks different depending on the time frame chosen. Medico Remedies trades on the NSE under the symbol MEDICO, and its 1M return of -45.62% compares with the Nifty 50's -4.22% over the same period.
The Medico Remedies vs Nifty 50 comparison matters because Medico Remedies is a single stock exposed to its own sector and company-specific developments, while the Nifty 50 spreads risk across 50 large companies. This article lines up Medico Remedies share price performance against the Nifty 50 across 1 month, 3 months, 6 months, 1 year, 3 years, using NSE closing data.
Also read – MAS Financial Services vs Nifty 50: Returns Compared
Click Here – Get Free Investment Predictions
Medico Remedies vs Nifty 50: Performance at a Glance
The table below sets out Medico Remedies vs Nifty 50 performance across the available time frames, measured from NSE closing prices up to 7 October 2026.
| Time Frame | Medico Remedies Return | Nifty 50 Return | Difference |
|---|---|---|---|
| 1 Month | -45.62% | -4.22% | -41.4% pp |
| 3 Months | -42.99% | -4.63% | -38.36% pp |
| 6 Months | -43.33% | -5.09% | -38.24% pp |
| 1 Year | -56.35% | -9.29% | -47.06% pp |
| 3 Years | -69.17% (Medico Remedies) | +15.89% (Nifty 50) | -85.05% pp |
On the Medico Remedies vs Nifty 50 scorecard, Medico Remedies has lagged the index over the most recent one-year window. Over the longer term the index has pulled ahead, a reminder that short-term outperformance does not always hold up over multi-year horizons.
Check the Univest Screener for live Medico Remedies and Nifty 50 data
Why the Medico Remedies vs Nifty 50 Gap Exists
Medico Remedies's stock can move quite differently from the Nifty 50 because it carries concentrated exposure to its own sector and business cycle, unlike the index which blends 50 companies across banking, IT, energy and consumer sectors. This is the main driver of the gap seen in the Medico Remedies vs Nifty 50 return table above.
A second factor behind the Medico Remedies vs Nifty 50 divergence is valuation and trading liquidity. Company-specific news, quarterly results and sector sentiment can move Medico Remedies's price sharply in either direction over short periods, while the Nifty 50's return reflects the blended earnings trajectory of its constituents and is far less exposed to any single stock's swings.
Download the Univest iOS App or Univest Android App to track Medico Remedies and Nifty 50 live on the go.
Medico Remedies vs Nifty 50: Has Medico Remedies Beaten the Benchmark?
Medico Remedies has not kept pace with the Nifty 50 over the past year, posting a return of -56.35% against the index's -9.29% over the same period.
Also read – Max Estates vs Nifty 50: Share Price Performance Compared
Risks of the Medico Remedies vs Nifty 50 Comparison
Reading too much into a Medico Remedies vs Nifty 50 comparison has real limitations that investors should weigh before drawing conclusions. Medico Remedies carries concentrated business and sector risk that a diversified index does not, and its trading volumes and price swings can differ meaningfully from the Nifty 50's more liquid, blended profile. A stock's 52-week range of Rs 20.47 to Rs 56.88 also shows the kind of volatility that a single-stock investment carries relative to a broad index.
Conclusion
Medico Remedies vs Nifty 50 highlights how a single stock's return path can differ from a diversified benchmark over different time horizons. Investors weighing the Medico Remedies vs Nifty 50 record should factor in Medico Remedies's volatility, liquidity and sector concentration alongside its return history, and consult a SEBI-registered advisor before making an allocation decision.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Has Medico Remedies outperformed the Nifty 50 in the last year?
Ans. No. Medico Remedies returned -56.35% over the past year while the Nifty 50 returned -9.29% over the same period, based on NSE closing prices to 7 October 2026.
How does Medico Remedies vs Nifty 50 look over 3 years?
Ans. Over three years Medico Remedies has returned -69.17% compared with the Nifty 50's +15.89%, so in the Medico Remedies vs Nifty 50 comparison the index has been ahead over this horizon.
What is the Medico Remedies share price today compared to Nifty 50?
Ans. Medico Remedies share price stood at Rs 22.17 on NSE, while the Nifty 50 traded at 22,776.10 based on the same closing data window.
What is the 52-week high and low of Medico Remedies?
Ans. Medico Remedies's 52-week high is Rs 56.88 and its 52-week low is Rs 20.47, based on NSE data.
Why does Medico Remedies show bigger price swings than the Nifty 50?
Ans. Medico Remedies carries concentrated exposure to its own sector and business cycle, while the Nifty 50 spreads risk across 50 large companies, so company-specific news moves Medico Remedies's price more sharply than the diversified index, a key reason the Medico Remedies vs Nifty 50 return gap varies across time frames.
Is Medico Remedies a good long-term investment compared to a Nifty 50 index fund?
Ans. Medico Remedies's suitability depends on an investor's risk appetite, since single-stock exposure carries higher concentration risk than a diversified Nifty 50 index fund; long-term investors should weigh the Medico Remedies vs Nifty 50 return history alongside the company's fundamentals and consult a SEBI-registered advisor.
Recent Articles
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
MEP Infrastructure Developers vs Nifty 50: Returns Compared
Menon Bearings vs Nifty 50: Share Price Performance Compared
Meghmani Organics vs Nifty 50: Share Price Performance Compared
Megastar Foods vs Nifty 50: Share Price Performance Compared
Meesho vs Nifty 50: Share Price Performance Compared

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





